Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 6/2002

Ausgabe 6/2002

Inhaltsverzeichnis ( 15 Artikel )

01.12.2002 | Research article | Ausgabe 6/2002 Open Access

Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer

Ian G Campbell, Simon W Baxter, Diana M Eccles, David YH Choong

01.12.2002 | Research article | Ausgabe 6/2002 Open Access

Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990–1999

Christina A Clarke PhD, Sally L Glaser, Dee W West, Rochelle R Ereman, Christine A Erdmann, Janice M Barlow, Margaret R Wrensch

01.12.2002 | Review | Ausgabe 6/2002

The importance of being a myoepithelial cell

Marie-Ange Deugnier, Jérôme Teulière, Marisa M Faraldo, Jean Paul Thiery, Marina A Glukhova

01.12.2002 | Research article | Ausgabe 6/2002 Open Access

Inhibition of E2-induced expression of BRCA1 by persistent organochlorines

Thomas Rattenborg, Irene Gjermandsen, Eva C Bonefeld-Jørgensen

01.12.2002 | Research article | Ausgabe 6/2002 Open Access

No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer

Amanda B Spurdle, John L Hopper, Xiaoqing Chen, Margaret RE McCredie, Graham G Giles, Beth Newman, Georgia Chenevix-Trench, KumKum Khanna

01.12.2002 | Review | Ausgabe 6/2002

Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function

Emma Marshman, Charles H Streuli

01.12.2002 | Commentary | Ausgabe 6/2002

Has tamoxifen had its day?

Michael Baum

01.12.2002 | Research article | Ausgabe 6/2002 Open Access

Expression and prognostic significance of lysozyme in male breast cancer

Carlos Serra, Francisco Vizoso, Lorena Alonso, Juan C Rodríguez, Luis O González, María Fernández, María L Lamelas, Luis M Sánchez, José L García-Muñiz, Aniceto Baltasar, Justo Medrano

01.12.2002 | Commentary | Ausgabe 6/2002

A new day dawns: women without oestrogen or is a balance best?

V Craig Jordan

01.12.2002 | Review | Ausgabe 6/2002

Progesterone receptors - animal models and cell signaling in breast cancer Diverse activation pathways for the progesterone receptor - possible implications for breast biology and cancer

Claudia Lanari, Alfredo A Molinolo

01.12.2002 | Review | Ausgabe 6/2002

Progesterone receptors - animal models and cell signaling in breast cancer: Implications for breast cancer of inclusion of progestins in hormone replacement therapies

Catherine Schairer

01.12.2002 | Commentary | Ausgabe 6/2002

Prolactin signaling and Stat5: going their own separate ways?

Cathrin Brisken, Ayyakkannu Ayyanan, Wolfgang Doppler

01.12.2002 | Viewpoint | Ausgabe 6/2002

Mutations in DNA damage response genes and breast cancer susceptibility

Robert B Clarke

01.12.2002 | Commentary | Ausgabe 6/2002

Estrogen–progestin replacement therapy: regulatory action needed

Malcolm C Pike, Ronald K Ross

01.12.2002 | Meeting report | Ausgabe 6/2002

Workshop on The Epidemiology of the ATMGene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002

Jonine L Bernstein, Daniela Seminara, Anne-Lise Børresen-Dale

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise